Inventaire - أصدقاؤك ومجتمعاتك هم أفضل مكتبة لك

Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973)

الكاتب

Jean-Pierre Pignon

منشور في: BMC Cancer

تاريخ النشر: 2018-08-06

اللغة: الإنجليزية

الموضوع الرئيسي: أبحاث السرطان, المرحلة الثانية للتجربة السريرية, العلاج الكيميائي

Cites articles 51

Date

العنوان

الكاتبون

2013-10-11

Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial

Eric Van Cutsem, Daniel Jaeck, Euan Walpole, John Primrose, Bengt Glimelius, Wolf Otto Bechstein
2013-01-01

Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy

Jeremie Lefevre, Valérie Boige, Matthieu Faron, Clarisse Dromain, Frédéric Dumont
2011-12-01

Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer

William R Jarnagin, Yuman Fong, Ronald P DeMatteo, Nancy E Kemeny, Leslie H Blumgart, Philip Paty
2010-12-01

Role of intra-arterial hepatic chemotherapy in the treatment of colorectal cancer metastases

T Peter Kingham, Michael D'Angelica
2010-04-01

Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases

Valérie Boige, Diane Goere
2010-01-04

Alternating systemic and hepatic artery infusion therapy for resected liver metastases from colorectal cancer: a North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) phase II intergroup trial, N99

Thomas C. Smyrk, Steven R Alberts, Michelle R. Mahoney
2008-09-15

Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials

Eric Van Cutsem
2008-03-22

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

Bengt Glimelius, Eric Van Cutsem, Daniel Jaeck, Wolf Otto Bechstein
2008-01-01

Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients.
2007-11-01

Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases

Karim Halazun, Giles J. Toogood
2007-10-24

Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: a retrospective analysis.

David J Gallagher
2007-02-23

Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents

William R Jarnagin, Yuman Fong, Ronald P DeMatteo, Nancy E Kemeny, Leslie H Blumgart, Michael D'Angelica
2007-02-01

Survival after hepatic resection in metastatic colorectal cancer: a population-based study
2007-08-01

Hepatic resection for colorectal metastases: value for risk scoring systems?

Cathy D. Schleck
2006-10-18

Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer metastatic to the liver

Sally Freels
2006-04-10

Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies

Jillian Leigh Colquitt
2006-02-27

Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).

Heinz-Josef Lenz
2006-04-01

A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer
2006-08-01

Epidemiology and management of liver metastases from colorectal cancer
2006-11-01

Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial
2005-09-01

Current strategies using hepatic arterial infusion chemotherapy for the treatment of colorectal cancer
2005-07-11

Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer

Valérie Boige, Marc Ychou, Erick Gamelin
2005-07-11

Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer

Mithat Gönen, William R Jarnagin, Yuman Fong, Ronald P DeMatteo, Nancy E Kemeny, Leslie H Blumgart, Philip Paty, Michael D'Angelica
2005-02-01

Hepatic arterial infusion after liver resection
2004-07-01

Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: comparative results with cisplatin using a rabbit VX2 tumor model

Olivier Rixe
2003-11-01

Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility
2003-02-01

Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial
2002-06-01

Trends in long-term survival following liver resection for hepatic colorectal metastases

Keith D Lillemoe, Richard D Schulick, Charles J Yeo
2002-03-01

Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy--an intergroup study
2001-11-01

Clinical predictors of recurrence site after hepatectomy for metastatic colorectal cancer
2001-11-01

Metastatic liver disease of colorectal origin: the value of locoregional immunochemotherapy combined with systemic chemotherapy following liver resection. Results of a prospective randomized study
2000-01-01

Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma

مقالة - wd:Q58799367

أهلًا وسهلًا إلى آنڤانتير

مكتبة أصدقائك ومجتمعاتك

تعلم المزيد